Does TOFACITINIB Cause Tenderness? 604 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 604 reports of Tenderness have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.4% of all adverse event reports for TOFACITINIB.
604
Reports of Tenderness with TOFACITINIB
0.4%
of all TOFACITINIB reports
16
Deaths
55
Hospitalizations
How Dangerous Is Tenderness From TOFACITINIB?
Of the 604 reports, 16 (2.6%) resulted in death, 55 (9.1%) required hospitalization, and 17 (2.8%) were considered life-threatening.
Is Tenderness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 604 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Tenderness?
METHOTREXATE (853)
ETANERCEPT (615)
ADALIMUMAB (561)
SECUKINUMAB (484)
SULFASALAZINE (294)
HYDROXYCHLOROQUINE (289)
PREDNISONE (278)
RITUXIMAB (262)
DICLOFENAC (258)
LEFLUNOMIDE (254)
Which TOFACITINIB Alternatives Have Lower Tenderness Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN